Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients
The DOI matches its Crossref record.
Abstract
Serum opsonophagocytic-killing titers often indicate the level of immune resistance to bacterial pathogens, yet in almost all cystic fibrosis (CF) patients that have chronic lung infections with mucoid Pseudomonas aeruginosa, high titers of opsonic-killing Abs can be measured and the infectious pathology still progresses through pulmonary failure and death. This anomalous finding may be due to the use of suspended cells of P. aeruginosa to evaluate phagocytic killing, whereas in the lungs of CF patients the organisms grow in a microcolony or biofilm, encased in mucoid exopolysaccharide (MEP, also called alginate). To determine whether the microcolony mode of growth contributes to bacterial resistance to host defenses, we evaluated opsonophagocytic killing of mucoid P. aeruginosa growing in a biofilm. Abs from infected CF patients were poorly able to mediate opsonic killing of biofilm, but not suspended, mucoid P. aeruginosa cells. Bacterial resistance to killing could be overcome by disruption of the biofilm layer with an enzyme that degrades MEP. Chronically infected CF patients also fail to produce opsonic-killing Abs specific to MEP, and when these Abs were evaluated in sera of older, noninfected CF patients and humans vaccinated with MEP, comparable killing of P. aeruginosa in biofilms and suspensions was obtained. In this case, C3 was deposited onto the MEP layer and could be visualized by fluorescence microscopy deposited throughout the biofilm. We conclude that opsonic Abs made by CF patients in response to chronic infection are ineffective at mediating phagocytic killing and elimination of bacterial cells growing as microcolonies in their lungs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
“The alginate layer of mucoid strains appears to prevent antibody coatings and blocks the immunological determinants required for opsonic phagocytosis (90, 91, 131, 135).”
BackgroundBiofilms: Microbial Life on Surfaces
Donlan, R. M. (2002) · Emerging Infectious Diseases · doi:10.3201/eid0809.020063 · Cited by 4,145
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
Self-citationEstablishment of infection: lessons from a versatile opportunist
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2000) · Microbes and Infection · doi:10.1016/s1286-4579(00)01259-4 · Cited by 1,341
Self-citationAlginate Overproduction Affects Pseudomonas aeruginosa Biofilm Structure and Function
Hentzer, M., Teitzel, G. M., Balzer, G. J., Heydorn, A., Molin, S., Givskov, M., & Parsek, M. R. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.18.5395-5401.2001 · Cited by 693
Leid, J. G., Willson, C. J., Shirtliff, M. E., Hassett, D. J., Parsek, M. R., & Jeffers, A. K. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.11.7512 · Cited by 525
Martínez, J. L., & Baquero, F. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.4.647-679.2002 · Cited by 514
Biofilms and chronic wound inflammation
Wolcott, R. D., Rhoads, D. D., & Dowd, S. E. (2008) · Journal of Wound Care · doi:10.12968/jowc.2008.17.8.30796 · Cited by 417
Clinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Sonnenburg, J. L., Angenent, L. T., & Gordon, J. I. (2004) · Nature Immunology · doi:10.1038/ni1079 · Cited by 404
Transmission of Yersinia pestis from an Infectious Biofilm in the Flea Vector
Jarrett, C. O., Deak, E., Isherwood, K. E., Oyston, P. C., Fischer, E. R., Whitney, A. R., Kobayashi, S. D., DeLeo, F. R., & Hinnebusch, B. J. (2004) · The Journal of Infectious Diseases · doi:10.1086/422695 · Cited by 268
Parkins, M. D., Ceri, H., & Storey, D. G. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02469.x · Cited by 263
Pier, G. B., Coleman, F., Grout, M., Franklin, M., & Ohman, D. E. (2001) · Infection and Immunity · doi:10.1128/iai.69.3.1895-1901.2001 · Cited by 258
Self-citationSarkisova, S., Patrauchan, M. A., Berglund, D., Nivens, D. E., & Franklin, M. J. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.13.4327-4337.2005 · Cited by 217
“aeruginosa pulmonary infections are considered biofilm-associated diseases, where the bacteria colonize the surface of pulmonary tissue (36), are often encapsulated in extracellular polysaccharide matrix material (25, 36, 48), secrete quorumsensing signaling compounds (58), and have increased resistance to antibiotics…”
BackgroundCady, N. C., McKean, K. A., Behnke, J., Kubec, R., Mosier, A. P., Kasper, S. H., Burz, D. S., & Musah, R. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038492 · Cited by 198
Powell, L. C., Pritchard, M. F., Ferguson, E. L., Powell, K. A., Patel, S. U., Rye, P. D., Sakellakou, S.-M., Buurma, N. J., Brilliant, C. D., Copping, J. M., et al. (2018) · npj Biofilms and Microbiomes · doi:10.1038/s41522-018-0056-3 · Cited by 189
Rogan, M. P., Taggart, C. C., Greene, C. M., Murphy, P. G., O’Neill, S. J., & McElvaney, N. G. (2004) · The Journal of Infectious Diseases · doi:10.1086/423821 · Cited by 171
“host’s killing mechanisms, such as phagocytosis [4].”
Berlutti, F., Morea, C., Battistoni, A., Sarli, S., Cipriani, P., Superti, F., Ammendolia, M. G., & Valenti, P. (2005) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200501800407 · Cited by 122
Pseudomonas aeruginosa: Recent Advances in Vaccine Development
Killough, M., Rodgers, A., & Ingram, R. (2022) · Vaccines · doi:10.3390/vaccines10071100 · Cited by 93
Metadata
- Authors
- Meluleni, G. J., Grout, M., Evans, D. J., & Pier, G. B.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1995-08
- Volume
- 155
- Issue
- 4
- Pages
- 2029-2038
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2166884052
- Cited by
- 129
- References
- 0
- FWCI
- 0.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.